Upon activation, complement proteins mediate several effector functions such as inflammatory cell and fibroblast recruitment to the tumor microenvironment, which stimulates extracellular matrix remodeling and consequently supports cancer progression [35]. The gene discussed is VTN; the disease is neoplasm.